Osaic Holdings
TPST icon

Osaic Holdings’s Tempest Therapeutics TPST Stock Holding History

Osaic Holdings’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67K Sell
1,513
-16
-1% -$26 ﹤0.01% 7332
2026
Q1 		$2.5K Sell
1,529
-84
-5% -$203 ﹤0.01% 6966
2025
Q4 		$4.62K Sell
1,613
-42
-3% -$297 ﹤0.01% 6754
2025
Q3 		$16.9K Sell
1,655
-179
-10% -$1.55K ﹤0.01% 6038
2025
Q2 		$12.5K Sell
1,834
-145
-7% -$1.03K ﹤0.01% 6022
2025
Q1 		$19K Hold
1,979
– – ﹤0.01% 5400
2024
Q4 		$21.3K Buy
1,979
+27
+1% +$349 ﹤0.01% 5297
2024
Q3 		$35.5K Hold
1,952
– – ﹤0.01% 4988
2024
Q2 		$55.6K Sell
1,952
-60
-3% -$2.6K ﹤0.01% 4595
2024
Q1 		$102K Hold
2,012
– – ﹤0.01% 4239
2023
Q4 		$115K Buy
+2,012
New +$95.3K ﹤0.01% 4336
2023
Q3 		– Sell
-8
Closed -$127 – 7540
2023
Q2 		$127 Hold
8
– – ﹤0.01% 7260
2023
Q1 		$232 Buy
+8
New +$175 ﹤0.01% 7245
2021
Q2 		– Hold
0
– – – 7128
2021
Q1 		– Sell
-3
Closed -$1.21K – 6948
2020
Q4 		$1K Buy
+3
New +$1.04K ﹤0.01% 6277
2020
Q3 		– Hold
0
– – – 6402
2020
Q2 		– Hold
0
– – – 6328
2020
Q1 		– Hold
0
– – – 6184

Other funds holding TPST

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Osaic Holdings's TPST Position: Q2 2026 in Review

Osaic Holdings reduced its Tempest Therapeutics (TPST) stake by 1% in Q2 2026, selling an estimated $26 and leaving 1,513 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #7332.

Osaic Holdings first reported a position in TPST in Q4 2020 and has held it in 14 quarters since. The position peaked at $115K in Q4 2023. 21 funds tracked by Wall St. Rank hold TPST as of Q2 2026.

  • Osaic Holdings held 1,513 shares of Tempest Therapeutics worth $1.67K as of Q2 2026.
  • Osaic Holdings sold 16 Tempest Therapeutics shares in Q2 2026, an estimated $26.
  • Tempest Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7332 holding.
  • Osaic Holdings first reported a position in Tempest Therapeutics in Q4 2020 and has held it in 14 quarters since.
  • Osaic Holdings's Tempest Therapeutics position peaked at $115K in Q4 2023.
  • 21 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.